India is looking to Peru healthcare market with a business delegation set to explore the country’s pharmaceutical and medical needs, a top Indian diplomat said on Friday.
[dropcap color=”#008040″ boxed=”yes” boxed_radius=”8px” class=”” id=””]S[/dropcap]andeep Chakravorty, India’s ambassador to Peru, said a delegation of 20 pharmaceutical companies will visit Peru to take part in a business forum with their Peruvian counterparts as part of Iphex-Latam 2016, from Aug. 22 to 23.
Peru imports about 800 million U.S. dollars worth of medications yearly, presenting an attractive market for pharmaceutical giants such as India, which merely sells 37 million U.S. dollars worth of medicine to Peru annually.
According to Chakravorty, India has also developed treatments for cancer, AIDS and heart-related ailments at more cost-effective prices than other countries.
Heart bypass surgery, for example, can cost about 10,000 dollars in India, while in Peru it can cost some 100,000 dollars, he said.
India is also willing to cooperate with the Peruvian government to expand health care services to the South American country’s remote and marginalized regions, he said.
Notes: Xinhua-(This story has not been edited by PGurus.com and is generated from a syndicated feed we subscribe to)
- Pentagon cancels aid to Pakistan over record on militants - September 2, 2018
- The curious case of Tamil Nadu’s opposition to NEET - September 4, 2017
- If 2.6 Billion People Go To War: India vs. China - July 22, 2017
